万维书刊网微信二维码

扫微信,关注编辑QQ!

投稿问答最小化  关闭

投稿有问题?问问网友吧!

我要提问

您的位置:万维书刊网 >>sci/scie期刊 >>医药卫生>>五官科学

Ophthalmic Genetics(研究方向:眼科学) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

Ophthalmic Genetics(季刊),创刊于1994年,出版国家为美国。杂志接受原创论文,评论文章和关于眼部疾病的临床和分子遗传方面的短篇报道。
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://www.tandfonline.com/loi/iopg20

3、期刊投稿:

https://mc.manuscriptcentral.com/nopg

4、信息说明:本刊信息来源于网络,包括SCI收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

201762日星期五

                      

 

Author Guidelines

 

All manuscripts are to be submitted via the Manuscript Central site http://mc.manuscriptcentral.com/nopg. Paper manuscripts are not accepted. Each manuscript must be accompanied by a statement that it has not been published elsewhere and that it has not been submitted simultaneously for publication elsewhere. Authors are responsible for obtaining permission to reproduce copyrighted material from other sources and are required to sign an agreement for the transfer of copyright to the publisher. As an author you are required to secure permission if you want to reproduce any figure, table or extract text from any other source. This applies to direct reproduction as well as "derivative reproduction" (where you have created a new figure or table which derives substantially from a copyrighted source).  Authors are required to sign an agreement for the transfer of copyright to the publisher. All accepted manuscripts, artwork, and photographs become the property of the publisher.

Declaration of interest:

 

It is the policy of all Taylor and Francis, to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE). ( http://www.icmje.org/index.html#conflict)

 

All authors must disclose any financial and personal relationships with other people or organizations that

could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or

materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.

 

All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading " Declaration of interest" and where available within the appropriate field on the journal’s Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.

 

If no conflict is declared, the following statement will be attached to all articles:

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

 

The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgments on conclusions drawn.

 

References:

 

Cite in the text by reference number. Prepare a numbered reference list. Cite up to four authors. If more than four authors, cite the first three followed by "et al." Examples:

 

Journal: Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997;123:199-206.

 

Online ahead of Print: Zhu CC, Traboulsi EI, Parikh S. Ophthalmological findings in 74 patients with mitochondrial disease. Ophthalmic Genet 2016; online first. doi:10.3109/13816810.2015.1130153

 

Book: Shields JA, Shields, CL. Intraocular tumors: a text and atlas. Philadelphia, PA: WB Saunders. 1992; 319.

 

Contribution to a Book: Kandagor V CC, Sanders CA, Greenbaum E, et al. In situ characterization of stimulating microelectrode arrays: Study of an idealized structure based on Argus II retinal implants. In: Zhou DD, Greenbaum E, editors. Implantable neural prostheses 2: Techniques and engineering approaches. 2nd ed. New York: Springer; 2010:139–156.

 

Tables and Figures: Tables and figures should not be embedded in the text, but should be included as

separate sheets or files. A short descriptive title should appear above each table with a clear legend and any footnotes suitably identified below. All units must be included. Figures should be completely labeled, taking into account necessary size reduction.

 

Captions should be typed, double-spaced, on a separate sheet. All original figures should be clearly marked with the number, author’s name, and top edge indicated.

Illustrations: Illustrations submitted (line drawings, halftones, photos, photomicrographs, etc.) should be clean originals or digital files. Digital files are recommended for highest quality reproduction and should follow these guidelines:

300 dpi or higher

sized to fit on journal page

EPS, TIFF, or PSD format only

submitted as separate files, not embedded in text files

   

Color Reproduction: Color art will be reproduced in color in the online publication at no additional cost to the author. Color illustrations will also be considered for print publication; however, the author will be required to bear the full cost involved in color art reproduction. Please note that color reprints can only be ordered if print reproduction costs are paid. Print Rates: $900 for the first page of color; $450 per page for the next three pages of color. A custom quote will be provided for articles with more than four pages of color. Art not supplied at a minimum of 300 dpi will not be considered for print.

 

Page Proofs: All proofs must be corrected and returned to the publisher within 48 hours of receipt. If the manuscript is not returned within the allotted time, the editor will proofread the article and it will be printed per the editor’s instruction. Only correction of typographical errors is permitted.

 

Complimentary Policy and Reprints: Authors for whom we receive a valid email address will be provided an opportunity to purchase reprints of individual articles, or copies of the complete print issue. These authors will also be given complimentary access to their final article on Taylor & Francis Online.

 

 

Open Access

 

Articles are eligible for Open Access. Electing this option allows the article to be made freely available online under a Creative Commons License. Authors of accepted papers will have the opportunity to purchase open access once production begins. Please note: This option is separate from Taylor and Francis's

NIH/Wellcome Fund policy.

NIH Research Policy

 

NIH policy: NIH-funded authors must submit to PMC, or have submitted on their behalf, at the point of acceptance, their peer-reviewed author manuscripts, to appear on PMC no later than 12 months after final publication.

 

In consideration of the National Institutes of Health (NIH) Public and Open Access Policies, the Taylor

and Francis journals group acknowledges that the broad and open dissemination of NIH -funded research results can benefit future scientific and medical research.

 

As part of our author services program, Taylor and Francis  will assist authors in depositing to PubMed Central (PMC) author manuscripts reporting NIH funded research, on specific request by the author. Upon this request, Taylor and Francis  will deliver to PMC the final peer-reviewed manuscript, which was accepted for publication and that reflects any author-agreed changes made in response to the peer review. We will also authorize the manuscript’s public access posting 12 months (NIH) after initial publication in print or electronic form (whichever is sooner). Following the deposit, authors will receive further communications from the NIH Manuscript Submission System with respect to the submission.

 

Authors wishing to submit their funded work to PMC themselves are welcome to do so providing they follow the terms stated – submitting only the final peer-reviewed manuscript which was accepted for publication (this manuscript must not be altered by Publisher’s copyediting and typesetting services) and

stating the 12 month (NIH) embargo period after final publication.

 

Please note that authors should not deposit post-print manuscripts directly to PMC or other third party sites for any systematic external distribution by a third party (e.g., to a listserv or database connected to a public access server).

 

All authors must comply with our editorial polices. 

 

编委会

 

主编辑:

Elias I. TraboulsiMD - 克利夫兰诊所眼科研究所遗传性眼疾病中心/ I319500 Euclid AvenueClevelandOH 44195USA。传真:+10216 445 2226

 

副主编:

Andreas Gal(主题:变异报告) - 德国汉堡

 

编辑助理

玛雅·Traboulsi

 

编委会:

Brian P. Brooks - BethesdaMDUSA

Helene Dollfus - 法国斯特拉斯堡

John Fingert - 美国爱荷华市IA

Christian Hamel - 法国蒙彼利埃

Alex Hewitt(主题:眼科遗传流行病学) - 澳大利亚东墨尔本

Yoshihiro Hotta - 浜松,日本

Stephanie A. Hagstrom - ClevelandOH

金子冰 - 温州,中国

Ulrich Kellner - 德国Siegberg

阿里巴底阿布扎比阿布扎比

Robert Koenekoop - 加拿大蒙特利尔

Bart Leroy - 根特比利时

理查德·刘易斯 - 休斯敦,德克萨斯州,美国

Dietmar Lohmann - 埃森,德国

Birgit Lorenz - 吉森,德国

澳大利亚珀斯大卫麦凯

Irene Hussels Maumenee - 芝加哥,IL,美国

安东尼·摩尔 - 伦敦,英国

Francis Munier(主题:视网膜母细胞瘤研究) - 瑞士洛桑

Markus Preising - 德国吉森

安东尼·罗布森 - 伦敦,英国

巴西圣保罗 - 圣保罗(Juliana Salloum

Mansoor Sarfarazi - 法明顿,CT,美国

丹尼尔·施德雷特 - 瑞士锡永

曾俊华 - 纽约,纽约,美国

弗吉尼亚M. Utz(主题:当前文学) - 辛辛那提,俄亥俄州,美国

安德烈·文森特 - 新西兰奥克兰

南开王 - 林口,台湾

理查德·韦伯(Richard Weleber - 美国俄勒冈州波特兰市


投稿问答最小化  关闭

投稿有问题?问问网友吧!

问答